Annual report pursuant to Section 13 and 15(d)

FAIR VALUE MEASUREMENTS (Details 2)

v3.19.3.a.u2
FAIR VALUE MEASUREMENTS (Details 2) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment $ 710 $ 591  
Asset Impairment Charges 767 591  
Goodwill and Intangible Asset Impairment   138  
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net     $ 150
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee     25
Nonrecurring gain (Loss) fair value adjustment (1,087) (1,627)  
North America      
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment 57    
Europe, Middle East and Africa      
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment 255 334  
Corporate      
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment     50
Asset Impairment Charges     50
Change to Plan of Sale Asset Adjustment 160    
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net     150
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee     25
Bottling Investments      
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment 406 205  
Asset Impairment Charges     737
Latin America      
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment 49 52  
Asia Pacific [Member]      
Assets measured at fair value on a nonrecurring basis      
Impairment of Intangible Assets (Excluding Goodwill) 42    
Venezuelan subsidiary | Corporate      
Assets measured at fair value on a nonrecurring basis      
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)     34
CCBA [Domain]      
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment 160    
Asset Impairment Charges   554  
CCBA [Domain] | Corporate      
Assets measured at fair value on a nonrecurring basis      
Equity Method Investment, Other than Temporary Impairment   554  
CCBA [Domain] | Bottling Investments      
Assets measured at fair value on a nonrecurring basis      
Asset Impairment Charges   554  
Philippine Bottling Operations [Member]      
Assets measured at fair value on a nonrecurring basis      
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss   32  
Philippine Bottling Operations [Member] | Corporate      
Assets measured at fair value on a nonrecurring basis      
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss   32  
North America Territory [Member]      
Assets measured at fair value on a nonrecurring basis      
Asset Impairment Charges   450 $ 737
Goodwill and Intangible Asset Impairment 42 138  
Tangible Asset Impairment Charges 0 312  
North America Territory [Member] | Bottling Investments      
Assets measured at fair value on a nonrecurring basis      
Asset Impairment Charges   450  
North America Territory [Member] | CCR [Member]      
Assets measured at fair value on a nonrecurring basis      
Asset Impairment Charges   312  
Property, Plant and Equipment [Member] | CCBA [Domain]      
Assets measured at fair value on a nonrecurring basis      
Asset Impairment Charges   225  
Change to Plan of Sale Asset Adjustment 34    
Finite-Lived Intangible Assets [Member] | CCBA [Domain]      
Assets measured at fair value on a nonrecurring basis      
Asset Impairment Charges 160 $ 329  
Change to Plan of Sale Asset Adjustment $ 126